Ingredients:
Active ingredient (I assume this is bird/pig/human engineered flu virus, which is listed as whole cell virus),vero cell line (diseased monkey tissue that the virus was grown on which will be present in the vaccine in trace amounts), haemmaglutinin, tween 80 (this is polysorbate 80), sodium chloride, tris (trometamol), water.
HAEMMAGLUTININ - This causes red blood cells to clump together.
Tween 80 - a stabilizer that is a known infertility agent. Linked to infertility in male painters and decorators due to it being in some paints. Used by the population council of WHO in developing pregnancy vaccines since the 1960's. I will post more info on this site soon about this.
Sodium Chloride - this is refined table salt which is bad for your heart and clogs up your arteries. It is particularly bad for children as they can't take as much salt as adults. A healthier kind of salt is sea salt or rock salt, rather than the refined version.
Tris - a buffer which is also an anti-inflammatory drug that has numerous side-effects including asthma and heart attack. Contraindications to Tris are:
Active or previous peptic ulcer. History of upper gastrointestinal bleeding or perforation, related to previous NSAID therapy.
• suspected or confirmed cerebrovascular bleeding
• haemorrhagic diatheses, including coagulation disorders
• hypersensitivity to ketorolac trometamol or other NSAIDs and those patients in whom aspirin or other prostaglandin synthesis inhibitors induce allergic reactions (severe anaphylactic-like reactions have been observed in such patients)
• the complete or partial syndrome of nasal polyps, angioedema or bronchospasm
• concurrent treatment with other NSAIDs including cyclooxygenase 2 specific inhibitors, oxpentifylline, probenecid or lithium salts
• hypovolaemia from any cause or dehydration
• moderate or severe renal impairment (serum creatinine > 160 micromol/l)
• a history of asthma
• severe heart failure
• patients who have had operations with a high risk of haemorrhage or incomplete haemostasis
• patients on anti-coagulants including low dose heparin (2500 - 5000 units twelve hourly)
• during pregnancy, labour, delivery or lactation
• children under 16 years of age
• Ketorolac is contra-indicated as prophylactic analgesia before surgery due to inhibition of platelet aggregation and is contra-indicated intra-operatively because of the increased risk of bleeding
• patients currently receiving aspirin
Despite the fact that Tris IS NOT SUITABLE FOR CHILDREN UNDER 16, IT IS IN THE SWINE FLU VACCINE WHICH WILL BE GIVEN TO CHILDREN UNDER THIS AGE.
A previous version of Celvapan which was a H5N1 vaccine (bird flu) had the following side effects:
Injection site reactions, headache, arthralgia, myalgia.
These were only THE MOST COMMON side-effects, the NHS did not include details of more serious side-effects for its staff.
THERE IS NO DATA YET FOR THE H1N1, swine/bird/human flu, I.E. THIS IS A BIG EXPERIMENT. THEY HAVE NO IDEA OF THE SAFETY BEFORE THEY INJECT YOUR CHILD!
INFORMATION NOT YET AVAILABLE!!!!
Ingredients:
Haemagglutinin, split cell virus grown in egg, Adjuvant (AS03)squalene, Alpha-tocopherol, polysorbate 80, Octoxynol 10, Sodium chloride, Disodium phosphate, Potassium dihydrogen phosphate, potassium chloride, magnesium chloride, thimerosal, water.
For heamagglutinin, polysorbate 80 and sodium chloride see further up page for explanations.
Alpha-tocopherol - E number E307.
Octoxynol 10 - A SPERMICIDE!!! According to doctor Jane Harrison-Hohner from Web MD,
"The active ingredients in spermicides are surfactants that attack the sperm membrane and immobilize the sperm: nonoxynol-9, -10, or -11, and octoxynol-9,-10, 13, and-40. Aerosol foams and creams tend to disperse better in the vagina; spermicides are also available as inserts and vaginal film."
The mind boggles as to why they are putting a known spermacide into a vaccine.
Disodium phosphate - a sodium salt of phosphoric acid used as an anti-caking agent.
Potassium dihydrogen phosphate - a food additive and fungacide.
Potassium Chloride - this is potassium and chlorine. Used in processed foods, medicines and in the LETHAL INJECTION. Too much potassium chloride paralysis's you so you are unable to breathe, hence it's use as a method of execution.
Magnesium Chloride - this is magnesium and chlorine, a powerful infection fighter and helps regenerate cells. They probably put that in there to counter all the crap they put in the vaccine.
Thimerosal - a 50% mercury compound, BANNED as an added ingredient from childhood vaccines but then the US introduced flu vaccines into the childhood schedule at the same time, which had thimerosal in them. Proven to cause developmental disorders and implicated in autism (See mercury, vaccines and autism page).
Squalene - an oil found in shark livers. Triggered arthritis in rats and implicated in Gulf War Syndrome.
THERE IS NO DATA YET FOR THE H1N1, swine/bird/human flu, I.E. THIS IS A BIG EXPERIMENT. THEY HAVE NO IDEA OF THE SAFETY BEFORE THEY INJECT YOUR CHILD!
INFORMATION NOT YET AVAILABLE!!!!
They want to give people 2 doses of vaccine, 3 weeks apart.
They want to vaccinate the following groups:
Priority groups:
Children aged 3 to 16 who are NOT high risk
Household contacts of the immuno-compromised
Those aged 16-64 who are not in the above groups
Health and social care workers.
Other groups:
Those less than 65 in high risk groups including pregnant women
Children under 5 years as part of the childhood immunisation schedule
School aged children in a schools based programme
All other adults.
http://209.85.229.132/search?q=cache:RbuvyWzwBe4J:www.nes.scot.nhs.uk/hai/pandemic_flu/documents/H1N1v1.003-08-09.pdf+Celvapan+data+sheet&cd=8&hl=en&ct=clnk&gl=uk&client=firefox-a
H1N1 Immunisation Programme - a resource pack to support the training of immunisers, nhs.
http://emc.medicines.org.uk/medicine/20922/SPC/Ketorolac%2030mg%20ml%20solution%20for%20injection%20(Beacon%20Pharmaceuticals)/#EXCIPIENTS
Data sheet for trometamol injection.
http://ajp.amjpathol.org/cgi/content/abstract/156/6/2057
http://boards.webmd.com/webx?THDX@@.89b5dc5b!thdchild=.89b5dc5b/0
Web MD page.
A harmless prick – and thereby possibly save thousands of people. This is what several hundreds of volunteers thought, who each collected a payment of 250 Euro for their participation in the study of the swine flu vaccine trial at the Ludwig-Maximilians-University.
One of them has now quit the trial: The Diploma-businessman Axel Sch. (40). He claims : "The vaccination has made me ill! – the test is irresponsible.” He says that within a few hours after the vaccination, on August 10, he had sweat on his forehead. "I felt totally beat. On the third day, my kidneys and head were aching and I got a fever. I then had a coughing fit - and the wash basin was suddenly red - it was blood!“
LMU-medical researcher Frank von Sonnenburg, who is in charge of the country-wide study, doesn’t consider these accounts credible. He says that such side-effects cannot be related to the vaccine. He does not deny that, as with other flu-vaccinations, flu-like symptoms may occur as a reaction to the vaccination. "Additionally, there may be light pain, redness or swelling at the injection site."
"Obviously many of the test subjects would have side-effects. We do such a study precisely because we want to find out any possible side-effects. If flu cases were to become more severe and we had not done any tests, – there would be a big outcry by everyone."
Was the vaccine admitted too quickly to the study? The fact is that in this composition, the vaccine has not yet been applied to humans. The Federal Health Minister Ulla Schmidt explained on Wednesday that she had felt put under pressure by the pharmaceutical industry from the beginning. Criticism is being voiced with increasing frequency. The Paul-Ehrlich-Institute points out that side-effects to this vaccine are to be more expected than in connection with a normal flu-vaccine. The Paediatric Association points to a possibly increased number of unknown side-effects.
British researchers even warn about a neurological disorder known as the Guillain-Barré-Syndrome. They point to a vaccination campaign with a similar swine flu vaccine carried out in the USA in 1976, which resulted in the deaths of 25 people.
Probably because of this, the USA only test vaccines without so-called adjuvants. These lead to greater side-effects, explains study leader Frank von Sonnenburg. "The adjuvants produce more anti-bodies, which is why the body’s defensive reaction is also greater." Kidney pains and bloody cough of the kind Axel Sch. Experienced were however not to be expected, even with this adjuvant. "We conduct a clean study."
Axel Sch. however insists that his complaints were a result of the vaccination. "Surely it is no coincidence that they occurred directly after the vaccination." He criticizes the university, saying that he was not properly informed prior to the study. He said that for three days he was flat on his back during this heat. "When I phoned the LMU, they simply asked me the question needed to fill in their form and told me to see my doctor." He now wants the medical costs and loss of earnings compensated by the medical insurance covering the trial.
Axel Sch. has participated in medical trials even when he was a student. He had also had good experiences with an LMU flu-vaccine study. "This is the reason why I immediately consented when they asked me if I would test the new vaccine."
Now his trust in research is gone, he is quitting the vaccine trial. In October he will fly to Latin America for professional reasons. He had looked forward to traveling unconcerned – by then he would have received the second of three vaccinations. "I’m not fearful just the same – I don’t belong to an at risk group. Also, the swine flu can’t possibly be as bad as the side-effects of the vaccine."
Translation into English by Erwin Alber.
Source: merkur-online.de, Münchner klagt über Horror-Nebenwirkungen – Forscher weisen Vorwürfe zurück, 21 August 2009.
In each experiment, four groups of six ferrets were immunized intramuscularly with an AS03 adjuvanted vaccine containing HA derived from H5N1/A/Vietnam/1194/04 (NIBRG-14). Doses of 15, 5, 1.7 or 0.6 micrograms of HA were tested in the homologous challenge experiment, and doses of 15, 7.5, 3.8 or 1.75 micrograms of HA were tested in the heterologous challenge experiment. Control groups included ferrets immunized with adjuvant alone, non-adjuvanted vaccine (15 micrograms HA) or phosphate buffered saline solution. Ferrets were vaccinated on days 0 and 21 and challenged by the intra-tracheal route on day 49 with a lethal dose of either H5N1/A/Vietnam/1194/04 or heterologous H5N1/A/Indonesia/5/05. Of the animals receiving adjuvanted vaccine, 87% and 96% were protected against the lethal homologous or heterologous challenge, respectively. Viral shedding into the upper respiratory tract was also reduced in vaccinated animals relative to controls, suggesting a reduced risk of viral transmission. In the unadjuvanted control group, as well as in the adjuvant control group, all animals died or had to be euthanized as they were moribund, three to four days after the start of challenge.
Split influenza virus, inactivated, containing antigen* equivalent to:
A/California/7/2009 (H1N1)v-like strain (X-179A) 3.75 micrograms**
* propagated in eggs
** haemagglutinin
This vaccine complies with the WHO recommendation and EU decision for the pandemic.
AS03 adjuvant composed of squalene (10.69 milligrams), DL-α-tocopherol (11.86 milligrams) and polysorbate 80 (4.86 milligrams)
The suspension and emulsion, once mixed, form a multidose vaccine in a vial. See section 6.5 for the number of doses per vial.
Excipients: the vaccine contains 5 micrograms thiomersal.
Suspension vial:
Polysorbate 80
Octoxynol 10
Thiomersal
Sodium chloride (NaCl)
Disodium hydrogen phosphate (Na2HPO4)
Potassium dihydrogen phosphate (KH2PO4)
Potassium chloride (KCl)
Magnesium chloride (MgCl2)
Water for injections
Emulsion vial:
Sodium chloride (NaCl)
Disodium hydrogen phosphate (Na2HPO4)
Potassium dihydrogen phosphate (KH2PO4)
Potassium chloride (KCl)
Water for injections
They have taken this information from trials of H5N1 (bird flu) vaccine, as NONE have been done on H1N1 vaccine!
Clinical studies have evaluated the incidence of adverse reactions listed below in approximately 5,000 subjects 18 years old and above who received formulations containing A/Vietnam/1194/2004 (H5N1) strain with at least 3.75 microgram HA/AS03.
Blood and lymphatic system disorders
Common: lymphadenopathy
Psychiatric disorders
Uncommon: insomnia
Nervous system disorders
Very common: headache
Uncommon: paraesthesia, somnolence, dizziness
Gastrointestinal disorders
Uncommon: gastro-intestinal symptoms (such as diarrhoea, vomiting, abdominal pain, nausea)
Skin and subcutaneous tissue disorders
Common: ecchymosis at the injection site, sweating increased
Uncommon: pruritus, rash
Musculoskeletal and connective tissue disorders
Very common: arthralgia, myalgia
General disorders and administration site conditions
Very common: induration, swelling, pain and redness at the injection site, fever, fatigue
Common: shivering, influenza like illness, injection site reactions (such as warmth, pruritus)
Uncommon: malaise.
Post-marketing surveillance of H1N1 vaccine - i.e. they only studied the vaccine AFTER they introduced it, as all effects listed above are for H5N1 vaccine, making YOU the experiment!
Immune system disorders
Anaphylaxis, allergic reactions
Nervous system disorders
Febrile convulsions
Skin and subcutaneous tissue disorders
Angioedema, generalised skin reactions, urticaria
Interpandemic trivalent vaccines
From Post-marketing surveillance with interpandemic trivalent vaccines, the following adverse reactions have also been reported:
Rare:
Neuralgia, transient thrombocytopenia.
Very rare:
Vasculitis with transient renal involvement.
Neurological disorders, such as encephalomyelitis, neuritis and Guillain Barré syndrome.
This medicinal product contains thiomersal (an organomercuric compound) as a preservative and therefore, it is possible that sensitisation reactions may occur (see section 4.4).
This was taken from H5N1 (bird flu) vaccination so they have NO PRE-CLINICAL SAFETY DATA ON H1N1 VACCINE!!
Non-clinical data obtained with the mock-up vaccine using a H5N1 vaccine strain reveal no special hazard for humans based on conventional studies of safety pharmacology, acute and repeated dose toxicity, local tolerance, female fertility, embryo-fetal and postnatal toxicity (up to the end of the lactation period).
There are currently no data available on the use of Pandemrix in pregnancy.
In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.
So you should not have other vaccines with this vaccine.
I think this information was taken from seasonal flu vaccine information, as nowhere in the ingredients or excipients can I find formaldehyde or gentamycin, so I think they have lifted it from that data sheet:
History of an anaphylactic (i.e. life-threatening) reaction to any of the constituents or trace residues (egg and chicken protein, ovalbumin, formaldehyde, gentamicin sulphate and sodium deoxycholate) of this vaccine. If vaccination is considered to be necessary, facilities for resuscitation should be immediately available in case of need.
There are no safety and immunogenicity data available from clinical studies with Pandemrix (H1N1) in children and adolescents aged from 3-17 years or in children aged less than 6 months. There are very limited data available from a clinical study with Pandemrix (H1N1) in healthy children aged from 6 to 35 months and limited data from a study with a version of Pandemrix containing H5N1 antigens in children aged from 3 to 9 years.
Very limited data in children aged 6 to 35 months (N=51) who received two doses of 0.25 ml (half of the adult dose) with an interval of 3 weeks between doses indicate an increase in the rates of injection site reactions and general symptoms (see section 4.8). In particular rates of fever (axillary temperature GREATER-THAN OR EQUAL TO (8805)38°C) may increase considerably after the second dose. Therefore, monitoring of temperature and measures to lower the fever (such as antipyretic medication as seems clinically necessary) are recommended in young children (e.g. up to approximately 6 years of age) after each vaccination.
There are no data on administration of AS03-adjuvanted vaccines before or following other types of influenza vaccines intended for pre-pandemic or pandemic use.
A protective immune response may not be elicited in all vaccinees.
Source: http://emc.medicines.org.uk/medicine/22352/SPC/Pandemrix+suspension+and+emulsion+for+emulsion+for+injection/#CLINICAL_PRECAUTIONS
An estimated 40 million doses of H1N1 vaccine expired Wednesday and will be thrown away, the U.S. Department of Health and Human Services, says. Federal officials say the expired vaccine accounts for nearly 25 percent of the 162 million doses of swine flu vaccine that were available for public use. The vaccine will be crushed and then incinerated.
According to HHS, an estimated 90 million doses of the vaccine was dispensed in 2009-2010. Eighty million Americans were vaccinated–about 25 percent of the population–children under 9 years old got two doses. Approximately 32 million doses remain in storage, set to expire at various times next year.
Source: CNN Health, 1st July 2010.
Sweden's Medical Products Agency opened an inquiry Wednesday into vaccinations for swine flu made by British pharmaceutical company GlaxoSmithKline, suspected of provoking narcolepsy.
"The MPA has received six reports from health care professionals regarding narcolepsy as suspected adverse drug reaction following Pandemrix flu vaccination," it said in a statement.
"The agency will, in consultation with external experts, assess the possible relationship between the vaccination and the reported reactions."
The reports concern children aged between 12-16 years who developed symptoms compatible with narcolepsy, a chronic sleeping disorder, that occurred one to two months after vaccination against the H1N1 pandemic.
The Medical Products Agency said it was in contact with European Union member states for information on any similar reports in other countries.
Finland is also looking into the possible link between narcolepsy and the swine flu vaccination, in particular Pandemrix, following an increase in the sleeping disorder among children this spring, the Finish news agency STT said.
The preliminary results from the investigation are expected by the end of this year.
In the European Union around 30 million people were vaccinated using Pandemrix. Sweden bought 18 million doses, which was enough to provide two injections for each person in its 9.3 million population.
According to Finland's National Health Institute, 2.5 million Finns were vaccinated against swine flu. Some 750 showed side effects, namely fevers, headaches and coughing, and one case was linked to narcolepsy.
Source: Google News, 19th August 2010.
Other pages:
This is the text-only version of this page. Click here to see this page with graphics.
Edit this page |
Manage website
Make Your Own Website: 2-Minute-Website.com